335-336
Editorial Commentary
Optimizing efavirenz treatment: CYP2B6 genotyping or therapeutic drug monitoring?
Margalida Rotger and Amalio Telenti
337-341
Review Article
Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: an evidence-based evaluation
Thrasivoulos George Tzellos and Dimitrios Kouvelas
343-346
Clinical Trial
An independent contribution to the growth of paediatric clinical pharmacology in Italy
Maurizio Bonati
347-355
Clinical Trial
The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis
Jaroslav Chládek, Marie Simková, Jaroslava Vanecková, Milos Hroch and Jirina Chládkova, et al.
357-365
Pharmacogenetics
High prevalence of the CYP2B6 516G→T(*6) variant and effect on the population pharmacokinetics of efavirenz in HIV/AIDS outpatients in Zimbabwe
Christopher Nyakutira, Daniel Röshammar, Emmanuel Chigutsa, Prosper Chonzi and Michael Ashton, et al.
367-372
Pharmacogenetics
The association of ABCB1 polymorphisms and elevated serum digitoxin concentrations in geriatric patients
Charalampos Dragonas, Jan T. Wagner, Hans J. Heppner, Thomas Bertsch and Wolfgang Muhlberg, et al.
373-379
Pharmacogenetics
Thiopurine S-methyltransferase activity in three major Asian populations: a population-based study in Singapore
Shirley Kow Yin Kham, Chin Kok Soh, Te Chih Liu, Yiong Huak Chan and Hany Ariffin, et al.
381-385
Pharmacogenetics
Induction of CYP1A2 by heavy coffee consumption in Serbs and Swedes
Natasa Djordjevic, Roza Ghotbi, Leif Bertilsson, Slobodan Jankovic and Eleni Aklillu
387-398
Pharmacokinetics and Disposition
Assessment of urinary mephenytoin metrics to phenotype for CYP2C19 and CYP2B6 activity
Tobias Klaassen, Alexander Jetter, Dorota Tomalik-Scharte, Dirk Kasel and Julia Kirchheiner, et al.
399-404
Pharmacokinetics and Disposition
Ritodrine pharmacokinetics in twin pregnancy patients
A. Konda, A. Nodai, M. Soma, Y. Koga and H. Yoshida, et al.
405-410
Pharmacoepidemiology and Prescription
Open AccessPrior outpatient antibiotic use as predictor for microbial aetiology of community-acquired pneumonia: hospital-based study
Ewoudt MW van de Garde, Henrik Endeman, Remco N van Hemert, G Paul Voorn and Vera HM Deneer, et al.
411-415
Pharmacoepidemiology and Prescription
Trends in the consumption of opioid analgesics in Spain. Higher increases as fentanyl replaces morphine
Javier Garcia del Pozo, Alfonso Carvajal, Jose Maria Viloria, Alfonso Velasco and Victorina Garcia del Pozo
417-424
Pharmacoepidemiology and Prescription
Equal access to treatment? Population-based follow-up of drugs dispensed to patients after acute myocardial infarction in Sweden
G. Ringbäck Weitoft, Ö. Ericsson, E. Löfroth and M. Rosén
425-432
Pharmacoepidemiology and Prescription
Adherence to statin therapy and patients’ cardiovascular risk: a pharmacoepidemiological study in Italy
Elisabetta Poluzzi, Petar Strahinja, Monica Lanzoni, Antonio Vargiu and Maria Chiara Silvani, et al.
433-437
Pharmacoepidemiology and Prescription
Diuretic drug therapy monitoring in the elderly: a cohort study
Marie Gérardin-Marais, Caroline Victorri-Vigneau, Gwenaëlle Allain-Veyrac, Anicet Chaslerie and Maryse Nicolas, et al.
439-444
Pharmacoepidemiology and Prescription
Use of desmopressin and concomitant use of potentially interacting drugs in elderly patients in Sweden
Rickard Ljung